Neumora Therapeutics, Inc. Common StockNMRANASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank80
3Y CAGR+23.8%
Year-over-Year Change
Net other income and expenses outside core operations
3Y CAGR
+23.8%/yr
Annual compound
Percentile
P80
Within normal range
vs 3Y Ago
1.9x
Solid growth
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $9.43M | -52.5% |
| 2024 | $19.86M | +141.8% |
| 2023 | $-47.46M | -1055.8% |
| 2022 | $4.97M | +45045.5% |
| 2021 | $11000.00 | +100.3% |
| 2020 | $-3.75M | - |